{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:54:13Z","timestamp":1785887653391,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lysophospholipids (LPLs) are known to have potentially important roles in the initiation and maintenance of neuropathic pain in animal models. This study investigated the association between the clinical severity of lumbar spinal stenosis (LSS) and the cerebrospinal fluid (CSF) levels of LPLs, using human samples. We prospectively identified twenty-eight patients with LSS and fifteen controls with idiopathic scoliosis or bladder cancer without neurological symptoms. We quantified LPLs from CSF using liquid chromatography-tandem mass spectrometry. We assessed clinical outcome measures of LSS (Neuropathic Pain Symptom Inventory (NPSI) and Zurich Claudication Questionnaire (ZCQ)) and categorized patients into two groups according to their severity. Five species of lysophosphatidic acid (LPA), nine species of lysophosphatidylcholine (LPC), and one species of lysophosphatidylinositol (LPI) were detected. The CSF levels of all species of LPLs were significantly higher in LSS patients than controls. Patients in the severe NPSI group had significantly higher LPL levels (three species of LPA and nine species of LPC) than the mild group. Patients in the severe ZCQ group also had significantly higher LPL levels (four species of LPA and nine species of LPC). This investigation demonstrates a positive correlation between the CSF levels of LPLs and the clinical severity of LSS. LPLs are potential biomarkers for evaluating the severity of LSS.<\/jats:p>","DOI":"10.1038\/s41598-019-45742-7","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:03:22Z","timestamp":1561370602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Kentaro","family":"Hayakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ohya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Oichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyuki","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baasanjav","family":"Uranbileg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kuwajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Sumitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-1896","authenticated-orcid":false,"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Chikuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"45742_CR1","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/BRS.0b013e3181d359bd","volume":"35","author":"C Schizas","year":"2010","unstructured":"Schizas, C. et al. Qualitative grading of severity of lumbar spinal stenosis based on the morphology of the dural sac on magnetic resonance images. Spine 35, 1919\u20131924, https:\/\/doi.org\/10.1097\/BRS.0b013e3181d359bd (2010).","journal-title":"Spine"},{"key":"45742_CR2","doi-asserted-by":"publisher","first-page":"E262","DOI":"10.1097\/01.brs.0000259922.82413.72","volume":"32","author":"H Aono","year":"2007","unstructured":"Aono, H. et al. Surgical outcome of drop foot caused by degenerative lumbar diseases. Spine 32, E262\u2013266, https:\/\/doi.org\/10.1097\/01.brs.0000259922.82413.72 (2007).","journal-title":"Spine"},{"key":"45742_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/00007632-199505150-00008","volume":"20","author":"JN Katz","year":"1995","unstructured":"Katz, J. N. et al. Clinical correlates of patient satisfaction after laminectomy for degenerative lumbar spinal stenosis. Spine 20, 1155\u20131160 (1995).","journal-title":"Spine"},{"key":"45742_CR4","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/00007632-199911010-00010","volume":"24","author":"JN Katz","year":"1999","unstructured":"Katz, J. N. et al. Predictors of surgical outcome in degenerative lumbar spinal stenosis. Spine 24, 2229\u20132233 (1999).","journal-title":"Spine"},{"key":"45742_CR5","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00586-010-1374-1","volume":"19","author":"N Hara","year":"2010","unstructured":"Hara, N. et al. Predictors of residual symptoms in lower extremities after decompression surgery on lumbar spinal stenosis. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 19, 1849\u20131854, https:\/\/doi.org\/10.1007\/s00586-010-1374-1 (2010).","journal-title":"European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"},{"key":"45742_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2106\/jbjs.e.00704","volume":"89","author":"AJ Haig","year":"2007","unstructured":"Haig, A. J. et al. Electromyographic and magnetic resonance imaging to predict lumbar stenosis, low-back pain, and no back symptoms. The Journal of bone and joint surgery. American volume 89, 358\u2013366, https:\/\/doi.org\/10.2106\/jbjs.e.00704 (2007).","journal-title":"The Journal of bone and joint surgery. American volume"},{"key":"45742_CR7","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1097\/01.brs.0000227370.65573.ac","volume":"31","author":"CM Lohman","year":"2006","unstructured":"Lohman, C. M., Tallroth, K., Kettunen, J. A. & Lindgren, K. A. Comparison of radiologic signs and clinical symptoms of spinal stenosis. Spine 31, 1834\u20131840, https:\/\/doi.org\/10.1097\/01.brs.0000227370.65573.ac (2006).","journal-title":"Spine"},{"key":"45742_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00586-008-0646-5","volume":"17","author":"M Sirvanci","year":"2008","unstructured":"Sirvanci, M. et al. Degenerative lumbar spinal stenosis: correlation with Oswestry Disability Index and MR imaging. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 17, 679\u2013685, https:\/\/doi.org\/10.1007\/s00586-008-0646-5 (2008).","journal-title":"European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"},{"key":"45742_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-9-89","volume":"9","author":"F Zeifang","year":"2008","unstructured":"Zeifang, F., Schiltenwolf, M., Abel, R. & Moradi, B. Gait analysis does not correlate with clinical and MR imaging parameters in patients with symptomatic lumbar spinal stenosis. BMC Musculoskelet Disord 9, 89, https:\/\/doi.org\/10.1186\/1471-2474-9-89 (2008).","journal-title":"BMC Musculoskelet Disord"},{"key":"45742_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbalip.2014.09.004","volume":"1851","author":"RP Oude Elferink","year":"2015","unstructured":"Oude Elferink, R. P., Bolier, R. & Beuers, U. H. Lysophosphatidic acid and signaling in sensory neurons. Biochimica et biophysica acta 1851, 61\u201365, https:\/\/doi.org\/10.1016\/j.bbalip.2014.09.004 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"45742_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nm1060","volume":"10","author":"M Inoue","year":"2004","unstructured":"Inoue, M. et al. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature medicine 10, 712\u2013718, https:\/\/doi.org\/10.1038\/nm1060 (2004).","journal-title":"Nature medicine"},{"issue":"Suppl 1","key":"45742_CR12","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/j.pain.0000000000000813","volume":"158","author":"H Ueda","year":"2017","unstructured":"Ueda, H. Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain. Pain 158(Suppl 1), S55\u2013s65, https:\/\/doi.org\/10.1097\/j.pain.0000000000000813 (2017).","journal-title":"Pain"},{"key":"45742_CR13","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1097\/j.pain.0000000000001316","volume":"159","author":"H Ueda","year":"2018","unstructured":"Ueda, H. et al. Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain. Pain 159, 2170\u20132178, https:\/\/doi.org\/10.1097\/j.pain.0000000000001316 (2018).","journal-title":"Pain"},{"key":"45742_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/ATVBAHA.114.304748","volume":"35","author":"M Kurano","year":"2015","unstructured":"Kurano, M. et al. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome. Arterioscler Thromb Vasc Biol 35, 463\u2013470, https:\/\/doi.org\/10.1161\/ATVBAHA.114.304748 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"45742_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cca.2007.10.005","volume":"388","author":"K Nakamura","year":"2008","unstructured":"Nakamura, K. et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clinica chimica acta; international journal of clinical chemistry 388, 51\u201358, https:\/\/doi.org\/10.1016\/j.cca.2007.10.005 (2008).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"45742_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-9-29","volume":"9","author":"L Ma","year":"2013","unstructured":"Ma, L., Nagai, J., Chun, J. & Ueda, H. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model. Molecular pain 9, 29, https:\/\/doi.org\/10.1186\/1744-8069-9-29 (2013).","journal-title":"Molecular pain"},{"key":"45742_CR17","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","volume":"35","author":"E Santos-Nogueira","year":"2015","unstructured":"Santos-Nogueira, E. et al. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury. The Journal of neuroscience: the official journal of the Society for Neuroscience 35, 10224\u201310235, https:\/\/doi.org\/10.1523\/JNEUROSCI.4703-14.2015 (2015).","journal-title":"Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"45742_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.201306-1014OC","volume":"188","author":"GY Park","year":"2013","unstructured":"Park, G. Y. et al. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med 188, 928\u2013940, https:\/\/doi.org\/10.1164\/rccm.201306-1014OC (2013).","journal-title":"Am J Respir Crit Care Med"},{"key":"45742_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2222.2006.02626.x","volume":"37","author":"SN Georas","year":"2007","unstructured":"Georas, S. N. et al. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 37, 311\u2013322, https:\/\/doi.org\/10.1111\/j.1365-2222.2006.02626.x (2007).","journal-title":"Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology"},{"key":"45742_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","volume":"41","author":"N Watanabe","year":"2007","unstructured":"Watanabe, N. et al. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. Journal of clinical gastroenterology 41, 616\u2013623, https:\/\/doi.org\/10.1097\/01.mcg.0000225642.90898.0e (2007).","journal-title":"Journal of clinical gastroenterology"},{"key":"45742_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2141.2008.07325.x","volume":"143","author":"A Masuda","year":"2008","unstructured":"Masuda, A. et al. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. British journal of haematology 143, 60\u201370, https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07325.x (2008).","journal-title":"British journal of haematology"},{"key":"45742_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.clinbiochem.2006.10.009","volume":"40","author":"K Nakamura","year":"2007","unstructured":"Nakamura, K. et al. Measurement of lysophospholipase D\/autotaxin activity in human serum samples. Clinical biochemistry 40, 274\u2013277, https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.10.009 (2007).","journal-title":"Clinical biochemistry"},{"key":"45742_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2006.09.022","volume":"204","author":"C Wessig","year":"2007","unstructured":"Wessig, C., Bendszus, M. & Stoll, G. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging. Experimental neurology 204, 14\u201319, https:\/\/doi.org\/10.1016\/j.expneurol.2006.09.022 (2007).","journal-title":"Experimental neurology"},{"issue":"2","key":"45742_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/ijms19020516","volume":"19","author":"Hozo Matsuoka","year":"2018","unstructured":"Matsuoka, H. et al. Neurotropin((R)) Accelerates the Differentiation of Schwann Cells and Remyelination in a Rat Lysophosphatidylcholine-Induced Demyelination Model. Int J Mol Sci 19, https:\/\/doi.org\/10.3390\/ijms19020516 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"45742_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-78","volume":"6","author":"J Nagai","year":"2010","unstructured":"Nagai, J. et al. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Molecular pain 6, 78, https:\/\/doi.org\/10.1186\/1744-8069-6-78 (2010).","journal-title":"Molecular pain"},{"key":"45742_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10517-011-1441-6","volume":"152","author":"EO Samodelkina","year":"2011","unstructured":"Samodelkina, E. O., Tsirkin, V. I. & Prokazova, N. V. Effect of lysophosphatidylcholine on alpha-adrenoreactivity of rat aorta smooth muscles. Bulletin of experimental biology and medicine 152, 15\u201318 (2011).","journal-title":"Bulletin of experimental biology and medicine"},{"key":"45742_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2016.11.022","volume":"258","author":"GP Campos-Mota","year":"2017","unstructured":"Campos-Mota, G. P., Navia-Pelaez, J. M., Araujo-Souza, J. C., Stergiopulos, N. & Capettini, L. S. A. Role of ERK1\/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine. Atherosclerosis 258, 108\u2013118, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.022 (2017).","journal-title":"Atherosclerosis"},{"key":"45742_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/wnl.0000000000001100","volume":"84","author":"GC Jickling","year":"2015","unstructured":"Jickling, G. C. & Montaner, J. Lysophosphatidylcholine to stratify risk of ischemic stroke in TIA. Neurology 84, 17\u201318, https:\/\/doi.org\/10.1212\/wnl.0000000000001100 (2015).","journal-title":"Neurology"},{"key":"45742_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/wnl.0000000000001093","volume":"84","author":"M Jove","year":"2015","unstructured":"Jove, M. et al. Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology 84, 36\u201345, https:\/\/doi.org\/10.1212\/wnl.0000000000001093 (2015).","journal-title":"Neurology"},{"key":"45742_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1097\/00007632-199609010-00024","volume":"21","author":"RW Porter","year":"1996","unstructured":"Porter, R. W. Spinal stenosis and neurogenic claudication. Spine 21, 2046\u20132052 (1996).","journal-title":"Spine"},{"key":"45742_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10555-011-9319-7","volume":"30","author":"AJ Houben","year":"2011","unstructured":"Houben, A. J. & Moolenaar, W. H. Autotaxin and LPA receptor signaling in cancer. Cancer metastasis reviews 30, 557\u2013565, https:\/\/doi.org\/10.1007\/s10555-011-9319-7 (2011).","journal-title":"Cancer metastasis reviews"},{"key":"45742_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.juro.2014.12.028","volume":"194","author":"M Kataoka","year":"2015","unstructured":"Kataoka, M. et al. Expression and Function of LPA1 in Bladder Cancer. The Journal of urology 194, 238\u2013244, https:\/\/doi.org\/10.1016\/j.juro.2014.12.028 (2015).","journal-title":"The Journal of urology"},{"key":"45742_CR33","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1194\/jlr.D048439","volume":"55","author":"M Okudaira","year":"2014","unstructured":"Okudaira, M. et al. Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS\/MS. J Lipid Res 55, 2178\u20132192, https:\/\/doi.org\/10.1194\/jlr.D048439 (2014).","journal-title":"J Lipid Res"},{"key":"45742_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira, D. et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108, 248\u2013257, https:\/\/doi.org\/10.1016\/j.pain.2003.12.024 (2004).","journal-title":"Pain"},{"key":"45742_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/0895-4356(95)00054-2","volume":"48","author":"G Stucki","year":"1995","unstructured":"Stucki, G., Liang, M. H., Fossel, A. H. & Katz, J. N. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 48, 1369\u20131378 (1995).","journal-title":"J Clin Epidemiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45742-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45742-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:43:22Z","timestamp":1671273802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45742-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45742"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45742-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9144"}}